González Santiago, Santiago | Oncología

Resultados: 80
Tipo Título / Nombre Autor(es) Año
A breast tissue-specific epigenetic clock provides accurate chronological age predictions and reveals de-correlation of age and DNA methylation in tumor-adjacent and tumor samples Garma LD, Pernas S, Fullana B, Vethencourt A..., González Santiago S 2026
Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study Garma LD, Pernas S, Vicente Baz D..., González Santiago S 2026
Protocolo de colitis secundaria a inmunoterapia Aroca Carpio CS, Moreno Fuentes E, Cerrudo Jiménez G, Ayala de Miguel P, González Santiago S 2026
Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer Ayala-de Miguel C, Quintana-Cortés L, González-Santiago S, Fuentes-Pradera J, Ayala-de Miguel P 2026
Impact of Immune-Related Adverse Event Frequency, Severity, and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non– Small Cell Lung Cancer Ayala de Miguel C, González Santiago S, Ayala de Miguel P 2026
Protocolo de Neumonitis secundaria a Inmunoterapia Moreno Fuentes E, Aroca Carpio CS, Espacio Santos PM, Ayala de Miguel P, González Santiago S, García García M, Gallego Domínguez R, Calle Pato U de la 2026
Diagnóstico temprano, monitorización y manejo del EPI/Neumonitis González Santiago S, Pérez Velasco R, Corral Peñafiel J 2025
Randomized phase II trial evaluating three anti-diarrheal prophylaxis strategies in patients (pts) with HER2+/HR+ early breast cancer (EBC) treated with extended adjuvant neratinib (dianer geicam/2018-06) Gil gil J, Ruiz Borrego M, Carrasco E..., González Santiago S 2025
Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial Bellet M, Tolosa P, Hernando C, Vidal M..., González Santiago S 2025
Carcinomas de ovario epiteliales de histología no serosa de alto grado: descripción y uso de IPARD a raíz de la experiencia en nuestro centro Espacio Santos PM, Pérez Velasco R, Cerrudo Jiménez G, Corral Morales J del, Soler Calvo M, JAramillo Cataño AN, Tejada Calvo P, Redondo Rosco ML, Larrud Ben Si Mohan I, Moreno Fuentes E, Aroca Carpio CS, García Obrero M, González Santiago S 2025